Kheiron Medical Technologies has formed a new U.S. partnership and is also supporting the breast imaging community with new tools.
The firm is collaborating with Stanford University to design functional proof-of-concept deep-learning models to enhance imaging for non-Hodgkin lymphoma patients. Under the Kaplan Project, the Stanford Center for Artificial Intelligence in Medicine & Imaging (AIMI Center) and Kheiron will partner to better stage the disease.
Kheiron's deep-learning technology will be applied to FDG-PET/CT images of lymphoma patients to improve radiologist efficiency and accuracy. Deep learning will support radiologists in the longitudinal assessment of whole-body FDG-PET/CT scans with the goal of reducing the time needed to evaluate a PET scan, improving throughput.
In other Kheiron news, the firm has launched RSViP, an AI-enabled tool that helps breast screening programs optimize scheduling for potential breast cancer patients by flagging higher-risk women.
The tool analyzes a woman's prior mammogram and assesses her case based on AI-detected signals of suspected lesions and the potential to develop breast cancer. RSViP then generates an actionable list that the breast screening scheduler can use to book appointments for women who may be most at risk of developing breast cancer. The firm recently concluded a successful pilot of RSViP with a large, multistate U.S. breast screening provider and is introducing the tool to breast screening programs in Europe and the Middle East.
Finally, Kheiron has launched its Mia IQ software device in the U.S., which uses AI to retrospectively review mammograms to identify potential discrepancies in breast positioning and compression. The software is compatible with full-field digital mammography (FFDM) images and will be available for 2D synthetic mammography images in the near future, according to the firm.
Kheiron is introducing Mia IQ to breast screening clinics in the U.S. as a training and audit tool, and based on this information, clinics can tailor and improve their technologist training programs. The firm developed the software in consultation with LRCB, the Dutch expert center for screening.
Kheiron plans to launch additional Mia IQ functionality next year that will offer expanded reporting capabilities for multisite breast screening clinics to enable cross-site comparison and individual technician education. The firm also plans to make Mia IQ PACS-compatible.
